![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 38, 27982-27990, September 22, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and Activation of Protein Kinase B/Akt Require Rab5*



1
From the
Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110 and
Life Sciences Institute, Departments of Internal Medicine and Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan 48109
Binding of insulin to the insulin receptor initiates a cascade of protein phosphorylation and effector recruitment events leading to the activation of multiple distinct signaling pathways. Previous studies suggested that the diversity and specificity of insulin signal transduction are accomplished by both subcellular localization of receptor and the selective activation of downstream signaling molecules. The small GTPase Rab5 is a key regulator of endocytosis. Three Rab5 isoforms (Rab5a, -5b, and -5c) have been identified. Here we exploited the RNA interference technique to specifically knock down individual Rab5 isoforms to determine the cellular function of Rab5 in distinct insulin signaling pathways. Small interference RNA against a single Rab5 isoform had no effect on protein kinase B (PKB)/Akt or MAPK activation by insulin in NIH3T3 cells overexpressing human insulin receptor. However, simultaneous knockdown of all three Rab5 isoforms dramatically attenuated PKB/Akt activation by insulin without affecting MAPK activation. This inhibition of PKB/Akt activation was because of the impaired interaction between insulin receptor substrate 1 and the p85
subunit of phosphatidylinositol 3-kinase. These results indicate a requirement of Rab5 in presenting p85 to insulin receptor substrate 1. Additional evidence supporting a role for Rab5 was suggested by studies with GAPex-5, a vps9 domain containing exchange factor. Down-regulation of GAPex-5 impaired insulin-stimulated PKB/Akt activation. Collectively, this study indicates the involvement of Rab5 in insulin signaling.
Received for publication, March 27, 2006 , and in revised form, June 26, 2006.
* This work was supported by National Institutes of Health Grants 2R01GM42259-33, 5R21DK065844-02, and R01DK061618-04. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Cell Biology and Physiology, Washington University School of Medicine, Campus Box 8228, 660 S. Euclid, St. Louis, MO 63110. Tel.: 314-361-6950; Fax: 314-361-1490; E-mail: pstahl{at}cellbiology.wustl.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
I. J. Lodhi, D. Bridges, S.-H. Chiang, Y. Zhang, A. Cheng, L. M. Geletka, L. S. Weisman, and A. R. Saltiel Insulin Stimulates Phosphatidylinositol 3-Phosphate Production via the Activation of Rab5 Mol. Biol. Cell, July 1, 2008; 19(7): 2718 - 2728. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. D. McLaughlin, A. Banerjee, S. Y. Khan, J. L. Lieber, M. R. Kelher, F. Gamboni-Robertson, F. R. Sheppard, E. E. Moore, G. W. Mierau, D. J. Elzi, et al. Platelet-Activating Factor-Mediated Endosome Formation Causes Membrane Translocation of p67phox and p40phox That Requires Recruitment and Activation of p38 MAPK, Rab5a, and Phosphatidylinositol 3-Kinase in Human Neutrophils J. Immunol., June 15, 2008; 180(12): 8192 - 8203. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuda, E. Kanno, K. Ishibashi, and T. Itoh Large Scale Screening for Novel Rab Effectors Reveals Unexpected Broad Rab Binding Specificity Mol. Cell. Proteomics, June 1, 2008; 7(6): 1031 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Smith, X. Su, R. El-Maghrabi, P. D. Stahl, and N. A. Abumrad Opposite Regulation of CD36 Ubiquitination by Fatty Acids and Insulin: EFFECTS ON FATTY ACID UPTAKE J. Biol. Chem., May 16, 2008; 283(20): 13578 - 13585. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saito, C. C. Jones, S. Huang, M. P. Czech, and P. F. Pilch The Interaction of Akt with APPL1 Is Required for Insulin-stimulated Glut4 Translocation J. Biol. Chem., November 2, 2007; 282(44): 32280 - 32287. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Su, C. Kong, and P. D. Stahl GAPex-5 Mediates Ubiquitination, Trafficking, and Degradation of Epidermal Growth Factor Receptor J. Biol. Chem., July 20, 2007; 282(29): 21278 - 21284. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kunita, A. Otomo, H. Mizumura, K. Suzuki-Utsunomiya, S. Hadano, and J.-E Ikeda The Rab5 Activator ALS2/alsin Acts as a Novel Rac1 Effector through Rac1-activated Endocytosis J. Biol. Chem., June 1, 2007; 282(22): 16599 - 16611. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kong, X. Su, P.-I Chen, and P. D. Stahl Rin1 Interacts with Signal-transducing Adaptor Molecule (STAM) and Mediates Epidermal Growth Factor Receptor Trafficking and Degradation J. Biol. Chem., May 18, 2007; 282(20): 15294 - 15301. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |